Skip to content
+1 (888) 687-4334 | sales@mountainside-medical.com
Free US shipping over $100
Free US shipping over $100
Login
Click or scroll to zoom
Tap or pinch to zoom
Abrysvo RSV Vaccine for Respiratory Syncytial Virus, Act-O-Vial by Pfizer.
Abrysvo RSV Vaccine for Respiratory Syncytial Virus, Act-O-Vial by Pfizer.

Abrysvo RSV Vaccine for Respiratory Syncytial Virus, Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)

by Pfizer USPG
Sale 36%
$ 699.95
$ 449.00
SKU 00069-2465-01
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

✔ Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)

Defend against Respiratory Syncytial Virus (RSV) with the Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG—the breakthrough, FDA-approved RSV vaccine for adults and maternal immunization. As recommended by the CDC, Abrysvo delivers advanced protection to high-risk populations, including adults 60+, pregnant women, and individuals with chronic health conditions.

Product Highlights & Top Health Benefits

  • Complete RSV Protection: Guards adults, seniors, and pregnant women against severe RSV infection, RSV pneumonia, and RSV-related bronchiolitis.
  • Single-Dose Act-O-Vial: Convenient 0.5 mL intramuscular injection, ideal for clinics, hospitals, and healthcare providers.
  • Pfizer Quality: Developed by Pfizer USPG, a world leader in vaccines and infectious disease prevention.
  • FDA Approved & CDC Recommended: Robust clinical studies support its efficacy and safety for respiratory syncytial virus immunization.
  • Maternal RSV Immunization: Protects newborns through passive immunity by vaccinating expectant mothers during pregnancy.
  • Senior & High-Risk Vaccination: Designed for adults aged 60 and above, as well as those with underlying conditions such as heart or lung disease.
  • Reduces Hospitalizations: Minimizes the risk of hospital visits and severe outcomes due to RSV.

Top Health terms for this Product:

  • Abrysvo RSV vaccine
  • RSV vaccine for adults
  • RSV vaccination for seniors
  • Respiratory syncytial virus vaccine
  • Pfizer RSV vaccine
  • FDA approved RSV vaccine
  • CDC recommended RSV vaccine
  • RSV vaccine side effects
  • Maternal RSV immunization
  • Best RSV vaccine for pregnancy
  • RSV shot for elderly
  • Prevent RSV in infants
  • RSV immunization schedule
  • Single dose RSV vaccine
  • Act-O-Vial RSV vaccine
  • Protection from RSV pneumonia
  • Vaccine for bronchiolitis prevention
  • Adult respiratory vaccines
  • Pregnancy vaccines for RSV
  • High-risk respiratory immunization

RSV is a leading cause of lower respiratory infections, pneumonia, and hospitalizations among adults 60 and older, people with chronic health conditions, and newborns via maternal transmission. The Abrysvo RSV Vaccine Act-O-Vial is formulated to deliver advanced, season-long protection. By choosing Abrysvo, you’re selecting:

  • Cutting-edge RSV prevention for seniors, adults, and expecting mothers.
  • Maternal vaccine protection that safeguards both mother and baby from severe RSV.
  • Confidence in vaccination with Pfizer’s proven safety, quality, and worldwide trust.
  • Alignment with the latest CDC and FDA RSV vaccine guidelines for high-risk patients.

Directions for Use

  • Dosage Form: 0.5 mL Act-O-Vial, single intramuscular dose
  • Indications: Adults 60+, pregnant women for maternal antibody transfer, and other at-risk individuals as per CDC and FDA guidance
  • Administration: By healthcare professional in clinics, hospitals, or physician’s offices
  • Storage: Refrigerate; do not freeze.

Safety & Side Effects

The Abrysvo RSV vaccine is well-tolerated and extensively tested. The most common side effects include mild injection site pain, fatigue, headache, and slight swelling—serious reactions are exceedingly rare. Always consult your healthcare provider before vaccination, especially regarding allergies or prior vaccine reactions.

Order Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Today

Stay protected this RSV season. The Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG is the leading choice for comprehensive RSV immunization in seniors, adults, high-risk groups, and pregnant women seeking to protect their infants. Make Abrysvo part of your immunization program and meet CDC vaccine requirements with confidence.

Buy Abrysvo RSV Vaccine today for industry-leading, FDA-approved protection against the risks of RSV pneumonia, bronchiolitis, and respiratory complications. Trust Pfizer—the name in respiratory health.

Abrysvo RSV Vaccine for Respiratory Syncytial Virus, Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)
Abrysvo RSV Vaccine for Respiratory Syncytial Virus, Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)
$ 699.95 $ 449.00
🔒 Medical License Required
Frequently Asked Questions, About the Abrysvo RSV Vaccine
  • What is the Abrysvo RSV Vaccine used for?

    Abrysvo is used to prevent respiratory syncytial virus (RSV) infection. It is primarily targeted towards older adults, as RSV can cause serious respiratory illnesses in this population.

  • What kind of vaccine is Abrysvo RSV?

    Abrysvo is a protein-based vaccine. It uses a stabilized form of a protein from the RSV virus to stimulate the immune system to provide protection.

  • How does the Abrysvo RSV Vaccine Work?

    Abrysvo works by introducing a protein that resembles a part of the virus, prompting the immune system to recognize it and build immunity. This helps the body fend off the actual virus if exposed in the future.

  • Is Abrysvo a one-time vaccine?

    As of now, Abrysvo is administered as a single dose. However, guidelines may evolve based on ongoing research and public health recommendations.

  • How often should I get the Abrysvo vaccine?

    Current recommendations suggest a single dose, but future guidelines could change based on further studies on long-term immunity.

  • How long has Abrysvo been around?

    Abrysvo was approved for use in 2023, so it is relatively new.

  • How long to wait between RSV and COVID vaccines?

    There is no strict waiting period between receiving the RSV and COVID vaccines. However, it's often recommended to allow enough time in between to monitor any potential side effects. Consult with a healthcare provider for personalized advice.

  • Who should avoid the RSV vaccine?

    Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. Always consult a healthcare provider to discuss potential risks.

  • What are the chances of getting Guillain-Barré from the RSV vaccine?

    The risk of Guillain-Barré syndrome from vaccines is generally very low. As of now, there is limited data on the precise risk associated with Abrysvo. Monitoring continues, and side effects are reported to health authorities.

  • What are the side effects of the RSV shot for seniors?

    Common side effects may include: Pain at the injection site Fatigue Headache Muscle pain Fever These side effects are usually mild and resolve on their own.

  • What are the problems with the Abrysvo vaccine?

    As with any new vaccine, there can be uncertainties and limited long-term data. Potential side effects, rare adverse reactions, and efficacy in diverse populations are areas that continue to be monitored. Always report any adverse effects to healthcare providers.

Search Any Type of Product, Medication, or Alignment

Get Notified When Back in Stock